Advertisement

Topics

Search Results for "Drugs From Pharmacia Corporation"

17:35 EDT 27th May 2017 | BioPortfolio

Matching Channels

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Antiplatelet drugs

Immunomodulating drugs

Diseasemodifying drugs

Cytotoxic drugs

Matching News

Enclara Pharmacia Appoints Stephen Phenneger as Chief Financial Officer

Thursday, April 6th 2017 at 3:24pm UTC Former operating partner at leading healthcare investment firm brings experience in growing healthcare companies PHILADELPHIA–(BUSINESS WIRE)– Enclar...

193,881 Orion Corporation A shares converted into B shares

  ORION CORPORATION      STOCK EXCHANGE RELEASE 27 JANUARY 2017 at 9.10 a.m. EET               193,881 Orion Corporation A shares converted into B shares In acco...

87,000 Orion Corporation A shares converted into B shares

ORION CORPORATION      STOCK EXCHANGE RELEASE 22 DECEMBER 2016 at 9.00 a.m. EET               87,000 Orion Corporation A shares converted into B shares In accor...

Early Warning News Release

TORONTO, ONTARIO -- (Marketwired) -- 02/14/17 -- As a result of an agreement effective February 13, 2017 in relation to the conversion of certain outstanding debt of The Jenex Corporation (the "Corp...

Oriola-KD Corporation's 50,375 A-shares converted into B-shares

Oriola-KD Corporation Stock Exchange Release 4 January 2017 at 9.00 a.m. Oriola-KD Corporation's 50,375 A-shares converted into B-shares In accordance with Section 3 of the Byla...

Enclara Pharmacia Appoints Stephen Phenneger As Chief Financial Officer

  Life Sciences Jobs   ...

Oriola-KD Corporation will publish its financial statements release 1 January-31 December 2016 on Monday, 13 February 2017 at 8.30 a.m.

Oriola-KD Corporation Stock Exchange Release 25 January 2017 at 1.00 p.m. Oriola-KD Corporation will publish its financial statements release 1 January-31 December 2016 on Monday, 13 ...

Intrinsic4D Inc. Announces Public Sale of Substantially all of the Assets of its Operating Subsidiary and Transfer to NEX

TORONTO, ONTARIO -- (Marketwired) -- 05/11/17 -- Intrinsic4D Inc. (the "Corporation") (TSX VENTURE: IFD) provides stakeholders with an update in relation to its financial status and solvency. Publi...

Matching PubMed Articles

Physicians' Trust in the FDA's Use of Product-Specific Pathways for Generic Drug Approval.

Generic drugs are cost-effective versions of brand-name drugs approved by the Food and Drug Administration (FDA) following proof of pharmaceutical equivalence and bioequivalence. Generic drugs are wid...

Comparing the Approval and Coverage Decisions of New Oncology Drugs in the United States and Other Selected Countries.

Global pharmaceutical sales for anticancer drugs were $74.4 billion in 2014, ranking first for drugs by therapeutic class. Countries may differ substantially in the approval and coverage decisions for...

Comparison of Generic-to-Brand Switchback Rates Between Generic and Authorized Generic Drugs.

Generic drugs contain identical active ingredients as their corresponding brand drugs and are pharmaceutically equivalent and bioequivalent, whereas authorized generic drugs contain both identical act...

Molecular dynamics study on DNA nanotubes as drug delivery vehicle for anticancer drugs.

In recent years, self-assembled DNA nanotubes have emerged as a type of nano-biomaterials with great potential for biomedical applications. To develop universal nanocarriers for smart and targeted dru...

A Systematic Literature Review Approach to Estimate the Therapeutic Index of Selected Immunosuppressant Drugs After Renal Transplantation.

Drugs that exhibit close margins between therapeutic and toxic blood concentrations are considered to have a narrow therapeutic index (NTI). The Food and Drug Administration has proposed that NTI drug...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement